Revenue: The sum of all revenue fields included for a company's operating activities.
Royalty Pharma PLC (RPRX) had Revenue of $630.58M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
|
Revenue |
$630.58M |
$294.69M |
|
-- |
|
$630.58M |
|
$67.54M |
|
$563.04M |
|
$-94.78M |
|
$468.26M |
|
$474.94M |
|
$468.26M |
|
$468.26M |
|
$468.26M |
|
$474.94M |
|
$563.04M |
|
$571.88M |
|
436.79M |
|
556.84M |
|
$0.67 |
|
$0.67 |
|
| Balance Sheet Financials | |
$1.43B |
|
$16.54B |
|
$18.39B |
|
$19.82B |
|
$535.68M |
|
$8.58B |
|
$9.34B |
|
$9.88B |
|
$9.94B |
|
$9.01B |
|
$9.94B |
|
1.00B |
|
| Cash Flow Statement Financials | |
$718.23M |
|
$-477.87M |
|
$-272.67M |
|
$618.70M |
|
$586.39M |
|
$-32.30M |
|
$121.99M |
|
$-222.34M |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.66 |
|
-- |
|
-- |
|
0.46 |
|
0.90 |
|
100.00% |
|
89.29% |
|
89.29% |
|
-- |
|
74.26% |
|
46.73% |
|
$265.87M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
22.92 |
|
3.93 |
|
4.71% |
|
5.20% |
|
2.36% |
|
2.53% |
|
$9.90 |
|
$0.48 |
|
$1.29 |
|